CNBC Explains: Vertex's cystic fibrosis drug combo
June 23, 2014 at 14:36 PM EDT
Vertex's Kalydeco was the first medicine to address the underlying genetic cause of the disease. A new drug combination, which combines Kalydeco with Lumacaftor, is designed to treat many additional cases.
